# Tuberculosis Research of INA-RESPOND On Drug Resistance

> **NCT02758236** · — · COMPLETED · sponsor: **Ina-Respond** · enrollment: 490 (actual)

## Conditions studied

- Lung Tuberculosis
- MDR TB

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT02758236
- **Lead sponsor:** Ina-Respond
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-13
- **Primary completion:** 2018-11-30
- **Final completion:** 2021-04-26
- **Target enrollment:** 490 (ACTUAL)
- **Last updated:** 2024-05-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02758236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02758236, "Tuberculosis Research of INA-RESPOND On Drug Resistance". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02758236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*